secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2021-08-09T23:59:59+00:00
Accession:  0000883984-21-000027
Event type: litigation
Sentiment:  positive
Materiality: 0.80
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical wins arbitration; Pfizer not entitled to up to $225M earn-out from 2017 Hospira deal
--------------------------------------------------------------------------------

- Arbitrator ruled on August 7, 2021 that performance targets for HIS earn-out liability were not met.
- Pfizer disputed ICU Medical's determination that the $191.3M to $225.0M earn-out was not payable.
- Pfizer received no payment in connection with the earn-out liability under the Restated Purchase Agreement.
- The dispute arose from the January 2017 acquisition of Pfizer's Hospira Infusion Systems business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/0000883984-21-000027-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398421000027/icui-20210807.htm
  HTML page:      https://secwatch.observer/filing/0000883984-21-000027

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer